FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220922479> ?p ?o ?g. }

• W4220922479 endingPage "e337" @default.
• W4220922479 startingPage "e329" @default.
• W4220922479 abstract "Multisystem inflammatory syndrome in children (MIS-C) is a rare but serious complication of infection with SARS-CoV-2. A possible involvement of pathogenetically relevant autoantibodies has been discussed. Recently, neutralising autoantibodies against inflammatory receptor antagonists progranulin and interleukin-1 receptor antagonist (IL-1Ra) were found in adult patients with critical COVID-19. The aim of this study was to investigate the role of such autoantibodies in MIS-C.In this multicentre, retrospective, cohort study, plasma and serum samples were collected from patients (0-18 years) with MIS-C (as per WHO criteria) treated at five clinical centres in Germany and Spain. As controls, we included plasma or serum samples from children with Kawasaki disease, children with inactive systemic juvenile idiopathic arthritis, and children with suspected growth retardation (non-inflammatory control) across four clinical centres in Germany and Spain (all aged ≤18 years). Serum samples from the CoKiBa trial were used as two further control groups, from healthy children (negative for SARS-CoV-2 antibodies) and children with previous mild or asymptomatic COVID-19 (aged ≤17 years). MIS-C and control samples were analysed for autoantibodies against IL-1Ra and progranulin, and for IL-1Ra concentrations, by ELISA. Biochemical analysis of plasma IL-1Ra was performed with native Western blots and isoelectric focusing. Functional activity of the autoantibodies was examined by an in vitro IL-1β-signalling reporter assay.Serum and plasma samples were collected between March 6, 2011, and June 2, 2021. Autoantibodies against IL-1Ra could be detected in 13 (62%) of 21 patients with MIS-C (11 girls and ten boys), but not in children with Kawasaki disease (n=24; nine girls and 15 boys), asymptomatic or mild COVID-19 (n=146; 72 girls and 74 boys), inactive systemic juvenile idiopathic arthritis (n=10; five girls and five boys), suspected growth retardation (n=33; 13 girls and 20 boys), or in healthy controls (n=462; 230 girls and 232 boys). Anti-IL-1Ra antibodies in patients with MIS-C belonged exclusively to the IgG1 subclass, except in one patient who had additional IL-1Ra-specific IgM antibodies. Autoantibodies against progranulin were only detected in one (5%) patient with MIS-C. In patients with MIS-C who were positive for anti-IL-1Ra antibodies, free plasma IL-1Ra concentrations were reduced, and immune-complexes of IL-1Ra were detected. Notably, an additional, hyperphosphorylated, transiently occurring atypical isoform of IL-1Ra was observed in all patients with MIS-C who were positive for anti-IL-1Ra antibodies. Anti-IL-1Ra antibodies impaired IL-1Ra function in reporter cell assays, resulting in amplified IL-1β signalling.Anti-IL-1Ra autoantibodies were observed in a high proportion of patients with MIS-C and were specific to these patients. Generation of these autoantibodies might be triggered by an atypical, hyperphosphorylated isoform of IL-1Ra. These autoantibodies impair IL-1Ra bioactivity and might thus contribute to increased IL-1β-signalling in MIS-C.NanoBioMed fund of the University of Saarland, José Carreras Center for Immuno and Gene Therapy, Dr Rolf M Schwiete Stiftung, Staatskanzlei Saarland, German Heart Foundation, Charity of the Blue Sisters, Bavarian Ministry of Health, the Center for Interdisciplinary Clinical Research at University Hospital Münster, EU Horizon 2020." @default.
• W4220922479 created "2022-04-03" @default.
• W4220922479 creator A5000529779 @default.
• W4220922479 creator A5001501948 @default.
• W4220922479 creator A5004951518 @default.
• W4220922479 creator A5005687029 @default.
• W4220922479 creator A5012490351 @default.
• W4220922479 creator A5023989766 @default.
• W4220922479 creator A5024886102 @default.
• W4220922479 creator A5025018832 @default.
• W4220922479 creator A5025765870 @default.
• W4220922479 creator A5029184162 @default.
• W4220922479 creator A5030342018 @default.
• W4220922479 creator A5035705996 @default.
• W4220922479 creator A5040230445 @default.
• W4220922479 creator A5043920787 @default.
• W4220922479 creator A5047051899 @default.
• W4220922479 creator A5050373267 @default.
• W4220922479 creator A5051567097 @default.
• W4220922479 creator A5051629956 @default.
• W4220922479 creator A5058919583 @default.
• W4220922479 creator A5061338585 @default.
• W4220922479 creator A5062202650 @default.
• W4220922479 creator A5062399704 @default.
• W4220922479 creator A5063047001 @default.
• W4220922479 creator A5064160876 @default.
• W4220922479 creator A5064684046 @default.
• W4220922479 creator A5068020609 @default.
• W4220922479 creator A5068183127 @default.
• W4220922479 creator A5069415812 @default.
• W4220922479 creator A5069417803 @default.
• W4220922479 creator A5072361777 @default.
• W4220922479 creator A5072381949 @default.
• W4220922479 creator A5075223532 @default.
• W4220922479 creator A5083604495 @default.
• W4220922479 creator A5090484271 @default.
• W4220922479 creator A5091521826 @default.
• W4220922479 creator A5091722687 @default.
• W4220922479 date "2022-05-01" @default.
• W4220922479 modified "2023-10-16" @default.
• W4220922479 title "Autoantibodies against interleukin-1 receptor antagonist in multisystem inflammatory syndrome in children: a multicentre, retrospective, cohort study" @default.
• W4220922479 cites W1952913830 @default.
• W4220922479 cites W1978634856 @default.
• W4220922479 cites W1987682660 @default.
• W4220922479 cites W1989658278 @default.
• W4220922479 cites W1998212202 @default.
• W4220922479 cites W2046700952 @default.
• W4220922479 cites W2068681851 @default.
• W4220922479 cites W2085865745 @default.
• W4220922479 cites W2129195110 @default.
• W4220922479 cites W2134104386 @default.
• W4220922479 cites W2136153080 @default.
• W4220922479 cites W2312943297 @default.
• W4220922479 cites W2880218695 @default.
• W4220922479 cites W3012797451 @default.
• W4220922479 cites W3024197490 @default.
• W4220922479 cites W3024521558 @default.
• W4220922479 cites W3025256562 @default.
• W4220922479 cites W3034016318 @default.
• W4220922479 cites W3037731101 @default.
• W4220922479 cites W3038003713 @default.
• W4220922479 cites W3043952641 @default.
• W4220922479 cites W3048960649 @default.
• W4220922479 cites W3083424448 @default.
• W4220922479 cites W3084924559 @default.
• W4220922479 cites W3087378474 @default.
• W4220922479 cites W3095683209 @default.
• W4220922479 cites W3107442582 @default.
• W4220922479 cites W3125248721 @default.
• W4220922479 cites W3126650956 @default.
• W4220922479 cites W3134797872 @default.
• W4220922479 cites W3161916665 @default.
• W4220922479 cites W3164248521 @default.
• W4220922479 cites W3167744464 @default.
• W4220922479 cites W3197836405 @default.
• W4220922479 cites W3198391307 @default.
• W4220922479 cites W3203047059 @default.
• W4220922479 doi "https://doi.org/10.1016/s2665-9913(22)00064-9" @default.
• W4220922479 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35368387" @default.
• W4220922479 hasPublicationYear "2022" @default.
• W4220922479 type Work @default.
• W4220922479 citedByCount "25" @default.
• W4220922479 countsByYear W42209224792022 @default.
• W4220922479 countsByYear W42209224792023 @default.
• W4220922479 crossrefType "journal-article" @default.
• W4220922479 hasAuthorship W4220922479A5000529779 @default.
• W4220922479 hasAuthorship W4220922479A5001501948 @default.
• W4220922479 hasAuthorship W4220922479A5004951518 @default.
• W4220922479 hasAuthorship W4220922479A5005687029 @default.
• W4220922479 hasAuthorship W4220922479A5012490351 @default.
• W4220922479 hasAuthorship W4220922479A5023989766 @default.
• W4220922479 hasAuthorship W4220922479A5024886102 @default.
• W4220922479 hasAuthorship W4220922479A5025018832 @default.
• W4220922479 hasAuthorship W4220922479A5025765870 @default.
• W4220922479 hasAuthorship W4220922479A5029184162 @default.
• W4220922479 hasAuthorship W4220922479A5030342018 @default.
• W4220922479 hasAuthorship W4220922479A5035705996 @default.
• W4220922479 hasAuthorship W4220922479A5040230445 @default.

• next